Alto Neuroscience, Inc. (ANRO)
$24.37+1.41%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $855M
- Beta
- 1.16
- P/E (TTM)
- -9.55
- Short % float
- 13.26%
- Days to cover
- 6.5
- SI change
- +11.7%
- 1W
- -1.73%
- 1M
- -23.07%
- vs SPY 1W
- -2.89%
- vs SPY 1M
- -26.07%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ANRO?
- LOPJLB’s latest quantitative signal on Alto Neuroscience, Inc. (ANRO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ANRO in?
- Alto Neuroscience, Inc. (ANRO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Alto Neuroscience, Inc. (ANRO) do?
- Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as…